66
Transcenta Holding Limited
6628.HK · HKSE
$0.80 -5.88% (-$0.05)
1M -4.71%
Market Cap ¥309.4M
P/E Ratio -
Div. Yield -
ROE 32.51%
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
4/9Valuation
50 /100
Fair P/S 42.73x
P/B 0.50x
P/E N/A
Growth
0 /100
Declining Rev. growth 58.58%
Book val. growth 25.14%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 562.61%
Net margin 2,740.08%
Op. margin 2,699.84%
Quality
0 /100
Poor ROIC 23.83%
ROE 32.51%
ROA 21.45%
Debt
46 /100
Moderate Debt/Equity 0.20x
Current ratio 0.25x
Int. coverage -30.97x
Stability
47 /100
Moderate Beta -0.47x
Rev. volatility 22.49%
EPS volatility 32.59%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about 6628.HK
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Xueming Qian
Employees
150
Headquarters
Suzhou
Upcoming events
31 MAR
Earnings
Upcoming earnings report